Infertility Market Size, Share, Leading Players and Demand Forecast Report 2023-2030
The global Infertility Market Size is anticipated to grow at
CAGR of 12.84 % and will reach a valuation of USD 3.65 billion during the
forecast period 2022-2030. Infertility
is a form of medical condition that is observed both in women and men. Simply
put, it is an individual’s inability of reproducing naturally. Some of the
common causes of infertility in men include abnormal sperm function or
production, genetic problems, diabetes mellitus, DNA damage, issues with
delivery of sperm, overexposure to specific environmental factors, damage
associated to cancer and more. Here the environmental factors include exposure
to pesticides, radiation, alcohol, smoking, taking certain medications and
regular exposure to heat.
Infertility Market Overview and
Analysis By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic
Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, And Other) And Women
Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing,
Hysterosalpingography And Others)) And General Diagnostic Tests (Genetic
Testing, Hormone Testing, Microscopic Analysis, Imaging, And Others), By Drugs
(Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment And Others), By
Techniques- Forecast 2030
There are
many factors that is driving the growth of the infertility market. Some of
these factors as per the Market Research Future (MRFR) report include declining
rate of fertility, increasing number of fertility clinics, advancements in
technology, increasing grants, funds and public-private investments, lifestyle
disorders, increasing awareness about infertility, accessibility of advanced infertility
treatment devices and treatment option and advent of various assisted
reproductive techniques.
Key Players
Key Infertility
Market Players include EMD Serono, Inc., Bayer Healthcare, Aetna Inc.,
Androvia LifeSciences, Zydus Cadila Healthcare Ltd, Andrology Solutions, SCSA
Diagnostics, Inc., Halotech DNA and others.
Market Segmentation
Market
Research Future report offers an all-inclusive segmental analysis of the Infertility
Market on the basis of sex, diagnosis, drugs and techniques.
Based on
sex, it is segmented into females and males. Of these, females will have the
largest share in the infertility market over the assessment period owing to
accessibility of a wide variety of treatment processes and decrease in female
fertility.
Based on
diagnosis, the infertility market is segmented into men diagnostic tests
(testicular biopsy, genetic testing, semen analysis and others), women
diagnostic tests (hysterosalpingography, ovulation testing, laparoscopy,
hysteroscopy and others) and general diagnostic tests (imaging, microscopic
analysis, hormone testing, genetic testing and others).
Based on
drugs, it is segmented into hormone treatment, serophene, letrozole, clomiphene
citrate and others.
Based on
techniques, the infertility market is segmented into surgery, intrauterine
insemination and assisted reproductive technology (ART). Surgery is further
segmented into tubal surgeries, hysteroscopic or laparoscopic surgery and
others. Of these, assisted reproductive technology (ART) will lead the market
owing to advancements in technology and lifestyle disorders.
Regional Analysis
Based on
region, the Infertility Market Research covers growth opportunities and
latest trends across North America, Europe, Asia Pacific and Middle East and
Africa. Of these, North America will dominate the market with the US being the
largest contributor in this region owing to favorable reimbursement scenario,
high income and rising pool of awareness. The infertility market in Europe will
have the second largest share and the major contributors in this region include
the UK, France and Germany. The key factor that is droving the growth of the
market in this region is the technological advancements being made in the
infertility treatment. The infertility market in the APAC region will be the
fastest growing, dominated by India and China. The factors that are driving the
growth of the market here include highest male infertility rate in South Asia
and large population having unmet needs.
Feb 2019-
Scientists have discovered a novel robotic sensor technology which can be
utilized for measuring hormones that affect sexual development, menstruation
and fertility cheaply and quickly than the current techniques. This technology
uses a RAPTER device that will provide clinicians with a more accurate and
faster hormone pulsatility diagnosis which affects the reproductive health and
result in more targeted and better treatments in case of women.
Global
Infertility Market Size, Analysis By 2023 | Top Companies EMD Serono, Inc.,
Bayer Healthcare, Aetna Inc., Androvia LifeSciences
Related Report-
Contraceptive
Pills Market Research Report- Global Forecast To 2027
Auto-Injectors
Market Research Report- Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment